Dystonia Clinical Trial
Official title:
Functional Connectivity of the Basal Ganglia in Primary Focal Dystonia
In this study we are looking at primary focal dystonias, including dystonias of the limbs,
eyes, jaw or face, neck, and vocal chords. This study will use magnet resonance imaging (MRI)
to see how the brain reacts while resting and doing a finger-tapping task.
The investigators will test the hypothesis that disturbances in functional connectivity
within the motor, affective and cognitive basal ganglia networks in primary focal dystonia
(PFD) underlie the motor and non-motor symptoms in this disorder.
After written consent is obtained, all subjects undergo a neurological examination by a board
certified neurologist and complete a Montreal Cognitive Assessment and Edinburgh Handedness
Inventory. Primary focal dystonia (PFD) patients will have their dystonia assessed with
commonly used clinical rating scales for dystonia using Unified Dystonia Rating
Scale,Fahn-Marsden Scale, Global Dystonia Rating Scale, Toronto Western Spasmodic Torticollis
Rating Scale—TWSTRS,and the Jankovic Rating Scale for blepharospasm. Patients and controls
will have affective symptoms assessed using the Liebowitz Social Anxiety Scale, Hospital
Anxiety and Depression Scale,Yale-Brown Obsessive Compulsive Scale,and Beck Depression
Inventory. Clinical evaluations will be performed at the University of Colorado Denver and
Denver Veterans Affairs (VA) Hospital Brain Imaging Center on the Anschutz Medical Campus,
prior to Magnetic Resonance Imaging (MRI) scanning. Consenting, exam, and clinical scale
assessments are estimated to take 30-40 minutes to complete.
MRI scanning protocol
MRI scanning will be performed using an 8-channel head coil and a 3 Tesla General Electric
(GE) Signa MR scanner system that is FDA-approved for clinical MR scanning. The principal
investigator and/or a co-investigator will be present for every scanning session. Head motion
will be minimized using cushions and passive restraints. The total MRI scanning session will
take approximately 50-60 minutes, including set-up time and scan time, and includes the
following MRI runs:
1. Anatomic scans: A high-resolution 3D spoiled gradient echo T1-weighted image (~8
minutes) will be collected for image registration and normalization. The subject simply
rests while the sequence is run. A diffusion tensor imaging (DTI) scan (~10 minutes)
will be acquired using a double spin-echo diffusion echo-planar imaging (EPI) sequence
and 32 diffusion directions.
2. Resting-state task (~6 min): Subject remains motionless with eyes closed and tries not
to sleep or think of anything in particular.
3. Motor tapping task (~6 min): Subject performs a sequential five-finger finger-tapping
sequence in 30 sec blocks that alternate with 30 sec of rest. The tapping task was
designed to minimize variance in performance between and within individuals and so is
paced with an audible cue. During the rest condition the subject is to remain motionless
and not think of anything in particular. A similar motor task has been shown to be
feasible in primary dystonia (PD) patients and lead to striatal dopamine release.
4. Repeat of motor task functional Magnetic Resonance Imagine (fMRI) scan (~6 minutes) -
subject uses opposite hand to perform sequential finger tapping task, but otherwise scan
is identical to above.
Behavioral assessments
1. Button presses during finger-tapping task scanning will be recorded using an
MRI-compatible five-button response unit.
2. Surface electromyographic (EMG) recordings will be obtained during resting-state and
motor task fMRI scans to assess spontaneous dystonic motor activity, movement during
rest, and muscle activity during tapping. Simultaneous EMG monitoring will be performed
using a EMG Amplifier designed for fMRI acquisition and small adhesive pad EMG
electrodes taped to the skin.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01433757 -
Ampicillin for DYT-1 Dystonia Motor Symptoms
|
Phase 1 | |
Recruiting |
NCT00971854 -
Alteration of Deep Brain Stimulation Parameters for Dystonia
|
N/A | |
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00169338 -
Pallidal Stimulation in Patients With Post-anoxic and Idiopathic Dystonia
|
Phase 2 | |
Completed |
NCT00004421 -
Deep Brain Stimulation in Treating Patients With Dystonia
|
Phase 2/Phase 3 | |
Terminated |
NCT03270189 -
Effect of the Visual Information Change in Functional Dystonia
|
N/A | |
Recruiting |
NCT02583074 -
Clinical Trial of STN-DBS for Primary Cranial-Cervical Dystonia
|
N/A | |
Recruiting |
NCT06117020 -
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
|
Phase 1 | |
Completed |
NCT01432899 -
Studying Childhood-Onset Hemidystonia
|
||
Completed |
NCT04948684 -
Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism
|
||
Completed |
NCT05106816 -
The Effects of Vibrotactile Stimulation in Patients With Movement Disorders
|
N/A | |
Recruiting |
NCT05027997 -
Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm
|
Phase 2 | |
Completed |
NCT00465790 -
Research of Biomarkers in Parkinson Disease
|
Phase 0 | |
Active, not recruiting |
NCT00142259 -
Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental Dystonia
|
Phase 4 | |
Recruiting |
NCT05663840 -
Effects of Exercise on Dystonia Pathophysiology
|
N/A | |
Not yet recruiting |
NCT06038097 -
Efficacy and Safety of Radiofrequency Pallidotomy in the Management of Dystonia
|
N/A | |
Recruiting |
NCT04286308 -
Cortical-Basal Ganglia Speech Networks
|
N/A | |
Active, not recruiting |
NCT03582891 -
The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy
|
N/A | |
Completed |
NCT03318120 -
Exercise Training in Dystonia
|
N/A | |
Completed |
NCT04568681 -
Deep Brain Stimulation Effects in Dystonia
|